phosphotyrosine has been researched along with decitabine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SY; Chiu, TY; Chiu, YL; Fan, CC; Hsieh, WC; Huang, TC; Huang, YJ; Hung, ZC; Juan, YH; Liao, JC; Lin, CT; Lin, RS; Lin, SY; Lin, XH; Liu, C; Lu, HH; Tsai, HC; Weng, RR; Wu, YC; Yu, CJ | 1 |
1 other study(ies) available for phosphotyrosine and decitabine
| Article | Year |
|---|---|
Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer.
Topics: Actin Cytoskeleton; Animals; Cell Line, Tumor; Cytoskeleton; Cytotoxicity, Immunologic; Decitabine; DNA (Cytosine-5-)-Methyltransferases; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Immunological Synapses; Isotope Labeling; Lung Neoplasms; Lymphocyte Activation; Lymphocyte Subsets; Male; Mice, Inbred NOD; Phosphotyrosine; Receptors, Antigen, T-Cell, gamma-delta; RNA, Messenger; Survival Analysis; Tumor Suppressor Protein p53; Up-Regulation; Xenograft Model Antitumor Assays | 2021 |